【结 构 式】 |
【分子编号】32767 【品名】2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]phenylformamide 【CA登记号】 |
【 分 子 式 】C16H16BrNO3 【 分 子 量 】350.21198 【元素组成】C 54.87% H 4.6% Br 22.82% N 4% O 13.71% |
合成路线1
该中间体在本合成路线中的序号:(VI)The enantioselective reduction of phenacyl bromide (I) with BH3.S(CH3)2 in THF catalyzed by the chiral borolidine (II) (obtained by reaction of (1R,2S)-1-amino-2-indanol (III) with BH3.S(CH3)2 in THF) gives the (R)-2-bromo-1-(4-benzyloxy-3-nitrophenyl)ethanol (IV), which is reduced with H2 over PtO2 in THF/toluene yielding the corresponding amino derivative (V). The reaction of (V) with formic acid and Ac2O affords the formamide (VI), which is condensed with the chiral (R)-N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine (VII) in THF/methanol providing the protected target compound (VIII). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C in ethanol. The intermediate the chiral (R)-N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine (VII) has been obtained by reductocondensation of 1-(4-methoxyphenyl)-2-propanone (IX) and benzylamine by hydrogenation with H2 over Pd/C in methanol yielding racemic N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine (X), which is submitted to optical resolution with (S)-mandelic acid to obtain the desired (R)-enantiomer (VII).
【1】 Hett, R.; et al.; Large-scale synthesis of enantio- and diastereomerically pure (R,R)-formoterol. Org Process Res Dev 1998, 2, 2, 96. |
【2】 Hett, R.; Senanayake, C.H.; Fang, K.Q.; Wald, S.A.; Redmon, M.P.; Gao, Y. (Sepracor Inc.); Formoterol process. US 6040344 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
15147 | Benzylamine; Phenylmethanamine | 100-46-9 | C7H9N | 详情 | 详情 | |
(I) | 32763 | 1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanone | C15H12BrNO4 | 详情 | 详情 | |
(II) | 32764 | (3aR,8aS)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3,2]oxazaborole | C9H10BNO | 详情 | 详情 | |
(III) | 27559 | (1R,2S)-1-amino-2,3-dihydro-1H-inden-2-ol | C9H11NO | 详情 | 详情 | |
(IV) | 32765 | (1R)-1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanol | 188690-82-6 | C15H14BrNO4 | 详情 | 详情 |
(V) | 32766 | (1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-bromo-1-ethanol | C15H16BrNO2 | 详情 | 详情 | |
(VI) | 32767 | 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]phenylformamide | C16H16BrNO3 | 详情 | 详情 | |
(VII) | 32738 | tert-butyl (2S,3S)-2-[(2-[[2-([[(1S,2S)-1-(tert-butoxycarbonyl)-2-methylbutyl]amino]carbonyl)phenyl]disulfanyl]benzoyl)amino]-3-methylpentanoate | C34H48N2O6S2 | 详情 | 详情 | |
(VIII) | 32769 | 5-((1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide | C33H36N2O4 | 详情 | 详情 | |
(IX) | 10038 | 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone | 122-84-9 | C10H12O2 | 详情 | 详情 |
(X) | 32770 | N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine; N-benzyl-1-(4-methoxyphenyl)-2-propanamine | C17H21NO | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)By reduction of a mixture of 1-(3-formylamino-4-hydroxyphenyl)-2-aminoethanol (VIII) and 1-(4-methoxyphenyl)-2-propanone (IX) with H2 over Pt in ethanol, followed by a treatment with fumaric acid (A).
【1】 Tanoury GJ, Hett R,Kessler D,et aL 2002. Taking advantage of polymorphism to effect an impurity removalt: development of a thermodynamic crystal form of (R,R)-fonnoterol tartnte. Org Proc Res Dev,6 (6).855~862 |
【1】 Murase, K.; et al.; JP 7512040 . |
【2】 Castaner, J.; Weetman, D.F.; BD 40A. Drugs Fut 1977, 2, 10, 639. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 23808 | Fumaric acid; (E)-2-butenedioic acid | 110-17-8 | C4H4O4 | 详情 | 详情 |
(I) | 66381 | (1R,2S)-1-Amino-2-indanol | 7480-35-5 | C9H11NO | 详情 | 详情 |
(II) | 32764 | (3aR,8aS)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3,2]oxazaborole | C9H10BNO | 详情 | 详情 | |
(III) | 32765 | (1R)-1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanol | 188690-82-6 | C15H14BrNO4 | 详情 | 详情 |
(IV) | 32766 | (1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-bromo-1-ethanol | C15H16BrNO2 | 详情 | 详情 | |
(V) | 32767 | 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]phenylformamide | C16H16BrNO3 | 详情 | 详情 | |
(VI) | 32738 | tert-butyl (2S,3S)-2-[(2-[[2-([[(1S,2S)-1-(tert-butoxycarbonyl)-2-methylbutyl]amino]carbonyl)phenyl]disulfanyl]benzoyl)amino]-3-methylpentanoate | C34H48N2O6S2 | 详情 | 详情 | |
(VII) | 32769 | 5-((1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide | C33H36N2O4 | 详情 | 详情 | |
(VIII) | 33905 | 5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenylformamide | C9H12N2O3 | 详情 | 详情 | |
(VIII) | 66382 | N-[2-Hydroxy-5-[1(R)-hydroxy-2-[2-(4-methoxyphenyl)-1(R)-methylethylamino]ethyl]phenyl]formamide | 67346-49-0 | C19H24N2O4 | 详情 | 详情 |
(IX) | 10038 | 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone | 122-84-9 | C10H12O2 | 详情 | 详情 |